Sanofi increased its revenue from €34.7 billion in FY 2016 to €43.6 billion in FY 2025. That’s a compound annual growth rate ...
AT&T remains a compelling portfolio candidate for dividend investors, supported by robust fundamentals and a disciplined capital return strategy. T has initiated significant share buybacks, totaling ...
David Harrell: Hi, I’m David Harrell, editor of the Morningstar DividendInvestor Newsletter. And I’m joined once again by Dave Sekera, who is Morningstar’s Chief US Market Strategist. Dave, thanks for ...